Program Description
This session, featuring case-based discussions, will explore how evolving evidence on dosing and guideline placement for CELMoD‑based combinations may impact treatment and management of relapsed/refractory multiple myeloma.
Sara Scott, PharmD
Clinical Pharmacy Specialist – Multiple Myeloma
Winship Cancer Institute of Emory University
Brooke Peteres, PharmD, BCOP
Clinical Pharmacy Services Manager, Pharmacy Operations
American Oncology Network
Danai Dima, MD
Assistant Professor
University of Washington School of Medicine
Accreditation Information
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Each CE broadcast/symposium is approved for 1.0 contact hours (0.10 CEU) of application-based credit.
Obtaining Credit
All participants who attended the live virtual broadcast need to
log on to their Pharmacy Times Continuing Education™ account on
www.pharmacytimes.org to complete an online evaluation form and request their
credit. Instructions on receiving credit will be provided the day of the event.